• 1
    Slattery ML,Edwards S,Curtin K,Schaffer D,Neuhausen S. Associations between smoking, passive smoking. GSTM-1, NAT2, and rectal cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 8829.
  • 2
    Luchtenborg M,White KK,Wilkens L,Kolonel LN,Le Marchand L. Smoking and colorectal cancer: different effects by type of cigarettes? Cancer Epidemiol Biomarkers Prev 2007; 16: 13417.
  • 3
    Paskett ED,Reeves KW,Rohan TE,Allison MA,Williams CD,Messina CR,Whitlock E,Sato A,Hunt JR. Association between cigarette smoking and colorectal cancer in the Women's Health Initiative. J Natl Cancer Inst 2007; 99: 172935.
  • 4
    Hooker CM,Gallicchio L,Genkinger JM,Comstock GW,Alberg AJ. A prospective cohort study of rectal cancer risk in relation to active cigarette smoking and passive smoke exposure. Ann Epidemiol 2008; 18: 2835.
  • 5
    Minami Y,Tateno H. Associations between cigarette smoking and the risk of four leading cancers in Miyagi Prefecture, Japan: a multi-site case-control study. Cancer Sci 2003; 94: 5407.
  • 6
    Nishino Y,Tsubono Y,Tsuji I,Komatsu S,Kanemura S,Nakatsuka H,Fukao A,Satoh H,Hisamichi S. Passive smoking at home and cancer risk: a population-based prospective study in Japanese nonsmoking women. Cancer Causes Control 2001; 12: 797802.
  • 7
    Nebert DW. Identification of genetic differences in drug metabolism: prediction of individual risk of toxicity or cancer. Hepatology 1991; 14: 398401.
  • 8
    Nebert DW,McKinnon RA,Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 1996; 15: 27380.
  • 9
    Tsuchida S,Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 1992; 27: 33784.
  • 10
    Chen K,Jiang QT,Ma XY,Yao KY,Leng SG,Yu WP,Zhou HG. Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study (in Chinese). Zhonghua Zhong Liu Za Zhi 2004; 26: 6458.
  • 11
    Slattery ML,Potter JD,Samowitz W,Bigler J,Caan B,Leppert M. NAT2. GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 107984.
  • 12
    van der Hel OL,Bueno de Mesquita HB,Sandkuijl L,van Noord PA,Pearson PL,Grobbee DE,Peeters PH. Rapid N-acetyltransferase 2 imputed phenotype and smoking may increase risk of colorectal cancer in women (Netherlands). Cancer Causes Control 2003; 14: 2938.
  • 13
    Greenblatt MS,Bennett WP,Hollstein M,Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 485578.
  • 14
    Slattery ML,Curtin K,Ma K,Schaffer D,Potter J,Samowitz W. GSTM-1 and NAT2 and genetic alterations in colon tumors. Cancer Causes Control 2002; 13: 52734.
  • 15
    Slattery ML,Curtin K,Anderson K,Ma KN,Ballard L,Edwards S,Schaffer D,Potter J,Leppert M,Samowitz WS. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000; 92: 18316.
  • 16
    Samowitz WS,Albertsen H,Sweeney C,Herrick J,Caan BJ,Anderson KE,Wolff RK,Slattery ML. Association of smoking. CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 2006; 98: 17318.
  • 17
    Spirio LN,Samowitz W,Robertson J,Robertson M,Burt RW,Leppert M,White R. Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps. Nat Genet 1998; 20: 3858.
  • 18
    Samowitz WS,Albertsen H,Herrick J,Levin TR,Sweeney C,Murtaugh MA,Wolff RK,Slattery ML. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005; 129: 83745.
  • 19
    Benlloch S,Paya A,Alenda C,Bessa X,Andreu M,Jover R,Castells A,Llor X,Aranda FI,Massuti B. Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology. J Mol Diagn 2006; 8: 5403.
  • 20
    Issa JP,Shen L,Toyota M. CIMP, at last. Gastroenterology 2005; 129: 11214.
  • 21
    Hoang JM,Cottu PH,Thuille B,Salmon RJ,Thomas G,Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997; 57: 3003.
  • 22
    Samowitz WS,Holden JA,Curtin K,Edwards SL,Walker AR,Lin HA,Robertson MA,Nichols MF,Gruenthal KM,Lynch BJ,Leppert MF,Slattery ML. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 2001; 158: 151724.
  • 23
    Samowitz WS,Slattery ML. Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas. Am J Pathol 1997; 151: 335.
  • 24
    Zhong S,Wyllie AH,Barnes D,Wolf CR,Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993; 14: 18214.
  • 25
    Bell DA,Taylor JA,Butler MA,Stephens EA,Wiest J,Brubaker LH,Kadlubar FF,Lucier GW. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993; 14: 168992.
  • 26
    Allen NE,Key TJ,Dossus L,Rinaldi S,Cust A,Lukanova A,Peeters PH,Onland-Moret NC,Lahmann PH,Berrino F,Panico S,Larranaga N, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2008; 15: 48597.
  • 27
    Slattery ML,Curtin K,Wolff RK,Boucher KM,Sweeney C,Edwards S,Caan BJ,Samowitz W. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum, in press.
  • 28
    Slattery ML,Curtin K,Ma K,Edwards S,Schaffer D,Anderson K,Samowitz W. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev 2002; 11: 5418.
  • 29
    Diergaarde B,Braam H,Vasen HF,Nagengast FM,van Muijen GN,Kok FJ,Kampman E. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 2007; 5: 73642.
  • 30
    Watson P,Ashwathnarayan R,Lynch HT,Roy HK. Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med 2004; 164: 242931.
  • 31
    Murtaugh MA,Ma KN,Sweeney C,Caan BJ,Slattery ML. Meat consumption patterns and preparation, genetic variants of metabolic enzymes, and their association with rectal cancer in men and women. J Nutr 2004; 134: 77684.
  • 32
    Lilla C,Verla-Tebit E,Risch A,Jager B,Hoffmeister M,Brenner H,Chang-Claude J. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 2006; 15: 99107.
  • 33
    Pfeifer GP,Denissenko MF,Olivier M,Tretyakova N,Hecht SS,Hainaut P. Tobacco smoke carcinogens. DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002; 21: 743551.
  • 34
    Weijenberg MP,Aardening PW,de Kok TM,de Goeij AF,van den Brandt PA. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study. Mutat Res 2008; 652: 5464.